Evidence map›Paper›PMID 17913891›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR.

Toby S Scott-Ward, Zhiwei Cai, Elizabeth S Dawson, Ann Doherty, Ana Carina Da Paula, Heather Davidson, David J Porteous, Brandon J Wainwright, Margarida D Amaral, David N Sheppard and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2020
    Review
  3. Article
  4. Structural mechanisms of CFTR function and dysfunction.The Journal of general physiology · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Potentiators exert distinct effects on human, murine, and Xenopus CFTR.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  10. Article
  11. Murine and human CFTR exhibit different sensitivities to CFTR potentiators.American journal of physiology. Lung cellular and molecular physiology · 2015
    Article
  12. Article
  13. Marked repression of CFTR mRNA in the transgenic Cftr(tm1kth) mouse model.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2014
    Article
  14. Article
  15. Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators.American journal of physiology. Lung cellular and molecular physiology · 2011
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Toby S Scott-WardDepartment of Physiology and Pharmacology, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom.
Zhiwei Cai
Elizabeth S Dawson
Ann Doherty
Ana Carina Da Paula
Heather Davidson
David J Porteous
Brandon J Wainwright
Margarida D Amaral
David N Sheppard
A Christopher Boyd

Funding

Biotechnology and Biological Sciences Research Council BB/C517517/1
6 · The paper itself

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl(-) channel gated by ATP-driven nucleotide-binding domain (NBD) dimerization. Here we exploit species differences between human and murine CFTR to investigate CFTR channel gating. Using homologous recombination, we constructed human-murine CFTR (hmCFTR) chimeras with sequences from NBD1, NBD2, or the regulatory domain (RD) of human CFTR replaced by the equivalent regions of murine CFTR. The gating behavior of hmRD and human CFTR were indistinguishable, whereas hmNBD1 and hmNBD2 had subtle effects on channel gating, prolonging both burst duration and interburst interval. By contrast, hmNBD1+2, containing both NBDs of murine CFTR, reproduced the gating behavior of the subconductance state of murine CFTR, which has dramatically prolonged channel openings. The CFTR potentiator pyrophosphate (PP(i)) enhanced human, hmRD, and hmNBD1 CFTR Cl(-) currents, but not those of hmNBD2, hmNBD1+2, and murine CFTR. By analyzing the rate-equilibrium free-energy relationships of chimeric channels, we obtained snapshots of the conformation of the NBDs during ATP-driven dimerization. Our data demonstrate that the conformation of NBD1 changes before that of NBD2 during channel opening. This finding suggests that NBD dimerization does not proceed by a symmetric tweezer-like motion, but instead in an asymmetric fashion led by NBD1. We conclude that the NBDs of murine CFTR determine the unique gating behavior of its subconductance state, whereas NBD2 controls channel potentiation by PP(i).

Indexed as

Adenosine TriphosphateAnimalsBinding SitesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDimerizationDiphosphatesHumansIn Vitro TechniquesIon Channel GatingKineticsMiceProtein Structure, TertiaryRecombinant Fusion ProteinsSpecies SpecificityAdenosine TriphosphateCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorDiphosphatesRecombinant Fusion Proteins

Identifiers

PMID17913891
PMCPMC2042212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.